CURE Childhood Cancer

Recent papers from CURE Childhood Cancer

1. Clinical and Epidemiological Characteristics of Infants <6 Months With Leukemia, Neuroblastoma, and Retinoblastoma in a Single Center in IranJournal of Pediatric Hematology/Oncology · 2026
2. Patient navigation as a core component of global cancer care—A call to action from the Global Alliance for Cancer Patient NavigationCancer · 2026
3. SIOP Standards Framework for Pediatric Oncology Units in Low‐ and Middle‐Income CountriesPediatric Blood & Cancer · 2026
4. The Surveillance of Bloodstream Infections in a German Pediatric Cancer Unit During a 5-Year Period: Microbial Spectrum, Antimicrobial Susceptibility and Effectiveness of Preventive Taurolidine LockThe Pediatric Infectious Disease Journal · 2026
5. Cancer treatments-related factors for subsequent soft-tissue sarcoma in childhood cancer survivorsESMO Open · 2026
6. ID #457 Brain tumours in First Nations children worldwide: Global patterns of incidence, survival, and structural inequityNeuro-Oncology Pediatrics · 2026
7. Timeliness of childhood cancer registration in Switzerland before and after implementation of the Cancer Registration ActEClinicalMedicine · 2026
8. Abstract 643: The Sean Karl Cohort: An international single-cell RNAseq study of paired patient Ewing sarcoma specimens.Cancer Research · 2026
9. Risk of Subsequent Primary Melanoma in 68,002 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup cohort studyJNCI Journal of the National Cancer Institute · 2026
10. Social inequalities in cancer in Germany: a call to actionJournal of Cancer Research and Clinical Oncology · 2026
11. Successful re-exposure to high-dose methotrexate after severely delayed methotrexate elimination and renal toxicity in children with acute lymphoblastic leukemiaHaematologica · 2026
12. N ′-(1-Phenylethylidene)benzohydrazide Cytotoxicity Is Lysine-Specific Demethylase 1 Independent and Linked to Iron–Sulfur Cluster Disruption in Ewing SarcomaACS Pharmacology & Translational Science · 2025
13. Risk Factors for Valvulopathy Among Childhood Cancer SurvivorsJAMA Oncology · 2025
14. Aberrant inheritance of extrachromosomal DNA amplifications promotes cancer evolution2025
15. Three Siblings With an Attenuated Presentation of Perlman Syndrome: A Case Report and Literature ReviewMolecular Genetics & Genomic Medicine · 2025
16. Childhood Cancer Survivors in Latin America: Insights Into Health Outcomes and Information NeedsPediatric Blood & Cancer · 2025
17. Conditional survival of children, adolescents and young adults (0–24 years) diagnosed with leukaemia during 2000–2014 world-wide: (CONCORD-3)European Journal of Cancer · 2025
18. Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancerEuropean Journal of Cancer · 2024
19. Prevalence of childhood cancer survivors in Europe: a scoping reviewEJC Paediatric Oncology · 2024
20. Implementation of the Short-Form 36 (SF-36) in childhood cancer survivors: An analysis on measurement properties across 5 European countries2024